Vertex Pharmaceuticals Inc (NASDAQ:VRTX) under-valued by 22%
| Website | https://www.vrtx.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $55,219,462,144 |
| Beta | 0.64373 |
| Average Volume | $2,095,237 |
| Last Dividend | 0% |
| Price on Feb 11, 2021 | $213.35 |
| Autochartist™ Valuation | $259.53 |
| Conclusion |
22% under-valued |
| Download Report |
